Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI
Open Access
- 13 February 2008
- journal article
- research article
- Published by Springer Nature in European Radiology
- Vol. 18 (5) , 931-938
Abstract
The appearance of malignant lesions in BRCA1 and BRCA2 mutation carriers (BRCA-MCs) on mammography and magnetic resonance imaging (MRI) was evaluated. Thus, 29 BRCA-MCs with breast cancer were retrospectively evaluated and the results compared with an age, tumor size and tumor type matched control group of 29 sporadic breast cancer cases. Detection rates on both modalities were evaluated. Tumors were analyzed on morphology, density (mammography), enhancement pattern and kinetics (MRI). Overall detection was significantly better with MRI than with mammography (55/58 vs 44/57, P = 0.021). On mammography, lesions in the BRCA-MC group were significantly more described as rounded (12//19 vs 3/13, P = 0.036) and with sharp margins (9/19 vs 1/13, P = 0.024). On MRI lesions in the BRCA-MC group were significantly more described as rounded (16/27 vs 7/28, P = 0.010), with sharp margins (20/27 vs 7/28, P < 0.001) and with rim enhancement (7/27 vs 1/28, P = 0.025). No significant difference was found for enhancement kinetics (P = 0.667). Malignant lesions in BRCA-MC frequently have morphological characteristics commonly seen in benign lesions, like a rounded shape or sharp margins. This applies for both mammography and MRI. However the possibility of MRI to evaluate the enhancement pattern and kinetics enables the detection of characteristics suggestive for a malignancy.Keywords
This publication has 32 references indexed in Scilit:
- Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancerBreast Cancer Research and Treatment, 2006
- Mammography, Breast Ultrasound, and Magnetic Resonance Imaging for Surveillance of Women at High Familial Risk for Breast CancerJournal of Clinical Oncology, 2005
- Expert heads a'rollingThe Lancet, 2005
- The development of interval breast malignancies in patients with BRCA mutationsCancer, 2004
- Overview of the main outcomes in breast-cancer prevention trialsThe Lancet, 2003
- A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false‐negative mammographyInternational Journal of Cancer, 2002
- Risk-Reducing Salpingo-oophorectomy in Women with aBRCA1orBRCA2MutationNew England Journal of Medicine, 2002
- Breast Density as a Predictor of Mammographic Detection: Comparison of Interval- and Screen-Detected CancersJNCI: Journal of the National Cancer Institute, 2000
- Differential Contributions ofBRCA1andBRCA2to Early-Onset Breast CancerNew England Journal of Medicine, 1997
- Risks of cancer in BRCA1-mutation carriersThe Lancet, 1994